The Commonwealth Fund (2022) recommended that efforts to control drug pricing should focus on five areas:Helping government to become a more responsible purchaser.Stopping patent abuses and anticompetitive practices that block price competition.Building a sustainable biosimilar market to create price competition.Fixing incentives in the drug supply chain and making the supply chain more transparent.Ensuring public accountability in the government-funded drug development process.What area, if any, is the most achievable in the short run ? ExplainUse 1 scholarly article
